{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:01:10Z","timestamp":1761948070757,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.pharma.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T17:48:36Z","timestamp":1432835316000},"page":"351-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and validation of HPLC-DAD method for the simultaneous determination of amoxicillin, metronidazole and rabeprazole sodium. Application to spiked simulated intestinal fluid samples"],"prefix":"10.1016","volume":"73","author":[{"given":"S.M.","family":"Sabry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Abdel-Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Mahgoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"volume":"Vol\u00a01","first-page":"202","year":"2009","key":"10.1016\/j.pharma.2015.04.008_bib0005"},{"issue":"11","key":"10.1016\/j.pharma.2015.04.008_bib0010","first-page":"128","article-title":"Spectrophotometric determination of rabeprazole sodium using two charge transfer complexation reactions","volume":"3","author":"Abdel-Hay","year":"2013","journal-title":"J Appl Pharm Sci"},{"issue":"4","key":"10.1016\/j.pharma.2015.04.008_bib0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1472-8206.2005.00340.x","article-title":"Eradication of Helicobacter pylori: recent advances in treatment","volume":"19","author":"McLoughlin","year":"2005","journal-title":"Fund Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2015.04.008_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fmb.10.25","article-title":"Helicobacter pylori eradication therapy","volume":"5","author":"Suzuki","year":"2010","journal-title":"Future Microbiol"},{"issue":"3","key":"10.1016\/j.pharma.2015.04.008_bib0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1523-5378.2011.00842.x","article-title":"Efficacy of 2-week, second-line helicobacter pylori eradication therapy using rabeprazole amoxicillin, and metronidazole for the Japanese population","volume":"16","author":"Hori","year":"2011","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.pharma.2015.04.008_bib0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1440-1746.2005.03889.x","article-title":"Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients","volume":"20","author":"Wong","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.pharma.2015.04.008_bib0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-007-0302-8","article-title":"Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy","volume":"63","author":"Shirai","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"22","key":"10.1016\/j.pharma.2015.04.008_bib0040","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2169\/internalmedicine.51.8510","article-title":"A multicenter prospective observational study of triple therapy with rabeprazole, amoxicillin and metronidazole for Helicobacter pylori in Japan","volume":"51","author":"Sugizaki","year":"2012","journal-title":"Internal Med"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2015.04.008_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2007.08.035","article-title":"Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium","volume":"350","author":"Ren","year":"2008","journal-title":"Int J Pharm"},{"first-page":"A310","year":"2010","series-title":"The British pharmacopoeia","key":"10.1016\/j.pharma.2015.04.008_bib0050"},{"first-page":"969","year":"2011","series-title":"The United States pharmacopoeia, 34th ed, The national formulary, 29th ed.","key":"10.1016\/j.pharma.2015.04.008_bib0055"},{"issue":"5","key":"10.1016\/j.pharma.2015.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jaoac\/92.5.1373","article-title":"Spectrofluorometry, thin layer chromatography, and column high-performance liquid chromatography determination of rabeprazole sodium in the presence of its acidic and oxidized degradation products","volume":"92","author":"Osman","year":"2009","journal-title":"J AOAC Int"},{"issue":"7","key":"10.1016\/j.pharma.2015.04.008_bib0065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/bmc.1177","article-title":"Simultaneous estimation of four proton pump inhibitors-lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study","volume":"23","author":"Bharathi","year":"2009","journal-title":"Biomed Chromatogr"},{"issue":"3\/4","key":"10.1016\/j.pharma.2015.04.008_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1365\/s10337-008-0670-y","article-title":"A validated, stability-indicating, LC method for rabeprazole sodium","volume":"68","author":"Buchireddy","year":"2008","journal-title":"Chromatographia"},{"key":"10.1016\/j.pharma.2015.04.008_bib0075","series-title":"Statistical methods in medical research","first-page":"283","author":"Armitage","year":"1994"},{"key":"10.1016\/j.pharma.2015.04.008_bib0080","series-title":"International conference on harmonisation","article-title":"Validation of analytical procedures: text and methodology, Q2(R1)","author":"ICH","year":"2005"},{"issue":"2","key":"10.1016\/j.pharma.2015.04.008_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0731-7085(02)00445-4","article-title":"Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products","volume":"31","author":"El-Gindy","year":"2003","journal-title":"J Pharm Biomed Anal"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450915000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450915000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:31:43Z","timestamp":1757719903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450915000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0003450915000528"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2015.04.008","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of HPLC-DAD method for the simultaneous determination of amoxicillin, metronidazole and rabeprazole sodium. Application to spiked simulated intestinal fluid samples","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}